Prevention and control of HPV infection and HPV-related cancers in Colombia- a meeting report

被引：11

作者：

Vorsters A. ^{[1
]}

Bosch F.X. ^{[2
,3
]}

Bonanni P. ^{[4
]}

Franco E.L. ^{[5
]}

Baay M. ^{[6
]}

Simas C. ^{[7
]}

Waheed D.-E.-N. ^{[1
]}

Castro C. ^{[8
]}

Murillo R. ^{[9
]}

Trujillo L. ^{[10
]}

Wiesner C. ^{[10
]}

Muñoz N. ^{[10
]}

机构：

[1] Centre for Evaluation of Vaccination, Vaccine and Infectious Diseases Institute, University of Antwerp, Universiteitsplein 1, Wilrijk Antwerp

[2] Cancer Epidemiology Research Program, IDIBELL, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona

[3] Open University of Catalonia, Barcelona

[4] University of Florence, Health Sciences, Florence

[5] Department of Oncology, McGill University, Montreal

[6] P95, Epidemiology and Pharmacovigilance Consulting and Services, Leuven

[7] Infectious Disease and Epidemiology (IDE), London School of Hygiene and Tropical Medicine, London

[8] Colombian League Against Cancer Bogota, Bogota

[9] Centro Javeriano de Oncología, Hospital Universitario San Ignacio, Bogota

[10] Instituto Nacional de Cancerología, Bogota

来源：

BMC Proceedings | / 14卷 / Suppl 9期

关键词：

Cervical cancer prevention; HPV; Human papilloma virus; Screening; Vaccination;

D O I：

10.1186/s12919-020-00192-2

中图分类号：

学科分类号：

摘要：

The Human Papillomavirus (HPV) Prevention and Control Board is an independent multidisciplinary board of international experts that disseminates relevant information on HPV to a broad array of stakeholders and provides guidance on strategic, technical and policy issues in the implementation of HPV control programs. In response to drastic drop of vaccine coverage following the adverse event crisis in Carmen del Bolivar, Colombia, the HPV Prevention and Control Board in collaboration with the Colombian National Cancer Institute and Colombian League Against Cancer convened a meeting in Bogota, Columbia (November 2018). The goal of the meeting was to bring together national and international group of experts to report the disease burden, epidemiology and surveillance of HPV and HPV-related cancers, to discuss the successes and especially the challenges of HPV vaccination and screening in Colombia, as well as the lessons learnt from neighbouring countries. The meeting provided a platform to confer various stakeholder's perspectives, including the role of the Colombian healthcare system and to catalyse various parts of the public health community in Colombia into effective action. The conclusion of the meeting included following suggestions to strengthen HPV prevention and control: 1) Re-introducing school-based vaccine programs, 2) Integrating primary and secondary prevention programs, 3) Developing an innovative crisis communication plan targeting healthcare workers, teachers and general population, 4) Building trust through efficient and timely communication, 5) Building strong relationship with media to ensure a stable vaccination campaign support, and 6) Promoting empathy among healthcare professionals towards patients to build trust and communicate effectively. © 2020 The Author(s).

引用

共 37 条

[1]

HPV Prevention and Control Board. Date Accessed 23 August 2019

[2]

Simas C., Munoz N., Arregoces L., Larson H.J., HPV vaccine confidence and cases of mass psychogenic illness following immunization in Carmen de bolivar, Colombia, Hum Vaccin Immunother, 15, 1, pp. 163-166, (2019)

[3]

Alvarez L.S., Salmon J.W., Swartzman D., The Colombian health insurance system and its effect on access to health care, Int J Health Serv, 41, pp. 355-370, (2011)

[4]

Sanz C., Out-of-sync Cancer care: Health insurance companies, biomedical practices, and clinical time in Colombia, Med Anthropol, 36, pp. 187-201, (2017)

[5]

Mosquera P.A., Hernandez J., Vega R., Labonte R., Sanders D., Dahlblom K., Et al., Challenges of implementing a primary health care strategy in a context of a market-oriented health care system: The experience of Bogota, Colombia, Int J Health Plann Manag, 29, pp. e347-e367, (2014)

[6]

Serra M., Ospina-Palacio D., Espinal S., Rodriguez D., Jadad A.R., Trusted Networks: The Key to Achieving World-class Health Results with A Reduced Budget, (2018)

[7]

Munoz N., Bosch F.X., De Sanjose S., Tafur L., Izarzugaza I., Gili M., Et al., The causal link between human papillomavirus and invasive cervical cancer: A population-based case-control study in Colombia and Spain, Int J Cancer, 52, pp. 743-749, (1992)

[8]

Munoz N., Bosch F.X., De Sanjose S., Herrero R., Castellsague X., Shah K.V., Et al., Epidemiologic classification of human papillomavirus types associated with cervical cancer, N Engl J Med, 348, pp. 518-527, (2003)

[9]

Castellsague X., Bosch F.X., Munoz N., Meijer C.J., Shah K.V., De Sanjose S., Et al., Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners, N Engl J Med, 346, pp. 1105-1112, (2002)

[10]

Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Et al., Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J Pathol, 189, pp. 12-19, (1999)

← 1 2 3 4 →